Chemoinformaics analysis of 2-Cyclohexen-1-ol, 2,4,4-trimethyl-
Molecular Weight | 140.226 | nRot | 0 |
Heavy Atom Molecular Weight | 124.098 | nRig | 6 |
Exact Molecular Weight | 140.12 | nRing | 1 |
Solubility: LogS | -2.102 | nHRing | 0 |
Solubility: LogP | 2.451 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 26.5007 |
nHD | 1 | BPOL | 16.0513 |
QED | 0.511 |
Synth | 3.649 |
Natural Product Likeliness | 2.733 |
NR-PPAR-gamma | 0.008 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.031 |
HIA | 0.007 |
CACO-2 | -4.309 |
MDCK | 0.0000231 |
BBB | 0.928 |
PPB | 0.710777 |
VDSS | 1.35 |
FU | 0.405234 |
CYP1A2-inh | 0.107 |
CYP1A2-sub | 0.706 |
CYP2c19-inh | 0.06 |
CYP2c19-sub | 0.872 |
CYP2c9-inh | 0.03 |
CYP2c9-sub | 0.93 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.844 |
CYP3a4-inh | 0.012 |
CYP3a4-sub | 0.241 |
CL | 8.806 |
T12 | 0.457 |
hERG | 0.014 |
Ames | 0.007 |
ROA | 0.031 |
SkinSen | 0.28 |
Carcinogencity | 0.108 |
EI | 0.977 |
Respiratory | 0.179 |
NR-Aromatase | 0.01 |
Antiviral | No |
Prediction | 0.941259 |